Trial intelligence / Profile preview

Rivaroxaban vs Enoxaparin for VTE Prophylaxis in Orthopedic Surgery

NCT03299296Phase 3Unknown

Start
Jan 2017
Primary completion
Jan 2018
01

Overview

A Phase 3 trial of rivaroxaban in venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE). Status: unknown.

02

Drugs

rivaroxaban
03

Conditions

venous thromboembolism (VTE)deep vein thrombosis (DVT)pulmonary embolism (PE)

Beyond the preview

Go deeper on NCT03299296.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03299296.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call